会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
    • 包含LORATADINE和PSEUDOEPHEDRINE的胶囊组合物
    • KR1020010006647A
    • 2001-01-26
    • KR1020000007697
    • 2000-02-18
    • 주식회사유한양행
    • 조항범박영준김현수
    • A61K9/16
    • A61K9/4808A61K9/1617A61K9/1635A61K9/1652A61K31/137A61K31/4545
    • PURPOSE: A capsule composition comprising loratadine and pseudoephedrine is provided which increases a dissolution rate of the loratadine in compared with a conventional tablet. Also, The pseudoephedrine or a salt thereof having a half-life shorter than the loratadine is delivered rapidly and continuously by dissolving from a sustained release pellet and a fast release pellet sequentially. The sustained release pellet coated with a wet-blocking agent exhibits a pseudo-multiple dissolution profile. CONSTITUTION: The capsule composition for oral administration comprises : (a) the fast release pellet (pellet A) comprising (i) a therapeutically effective amount of the loratadine; (ii) the pseudoephedrine or a pharmaceutically acceptable salt thereof and (iii) one or more of pharmaceutically acceptable additives; (b) the sustained release pellet (pellet B) comprising (i) the pseudoephedrine or the pharmaceutically acceptable salt thereof and (ii) one or more of pharmaceutically acceptable additives, wherein the pellet B is coated with 2-30 wt% of a water insolubility polymer and 2-30 wt% of the wet-blocking agent selected from magnesium stearate, talc, fatty acid ester or a mixture thereof.
    • 目的:提供包含氯雷他定和伪麻黄碱的胶囊组合物,其与常规片剂相比增加氯雷他定的溶出速率。 此外,通过从持续释放颗粒和快速释放颗粒中顺次溶解,快速且连续地递送具有比氯雷他定更短的半衰期的伪麻黄碱或其盐。 涂覆有湿阻塞剂的持续释放丸剂显示伪多重溶解曲线。 构成:用于口服给药的胶囊组合物包括:(a)快速释放颗粒(颗粒A),其包含(i)治疗有效量的氯雷他定; (ii)伪麻黄碱或其药学上可接受的盐,和(iii)一种或多种药学上可接受的添加剂; (b)持续释放丸粒(丸粒B),其包含(i)伪麻黄碱或其药学上可接受的盐和(ii)一种或多种药学上可接受的添加剂,其中颗粒B用2-30重量%的水 不溶性聚合物和选自硬脂酸镁,滑石,脂肪酸酯或其混合物的湿粘结剂的2-30重量%。